Impel NeuroPharma IPO

Impel NeuroPharma is a biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases.

Register for Details

For more details on financing and valuation for Impel NeuroPharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Impel NeuroPharma's ticker symbol?


What is Impel NeuroPharma's stock price?

0.55 as of 9/22/23

Learn more about Impel NeuroPharma

Forge green plus iconForge green minus icon

What is Impel NeuroPharma funding to date?

Impel NeuroPharma has raised $122.85MM to date.
Forge green plus iconForge green minus icon

When was Impel NeuroPharma founded?

Impel NeuroPharma was founded in 2008.
Updated on: Jun 12, 2022